tiprankstipranks
Trending News
More News >
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market

Werewolf Therapeutics (HOWL) Income Statement

Compare
645 Followers

Werewolf Therapeutics Income Statement

Last quarter (Q4 2024), Werewolf Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Werewolf Therapeutics's net income was $-20.40M. See Werewolf Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.89M$ 19.94M$ 16.40M$ 0.00$ 0.00
Gross Profit
$ 1.89M$ -18.96M$ 13.89M$ -735.00K$ -777.00K
Operating Expenses
$ 75.48M$ 60.45M$ 72.46M$ 50.09M$ 22.40M
Depreciation and Amortization
$ 1.81M$ 1.76M$ 2.51M$ 735.00K$ 777.00K
EBITDA
$ -64.05M$ -32.47M$ -51.30M$ -49.25M$ -14.26M
Operating Income
$ -73.59M$ -40.50M$ -56.06M$ -50.09M$ -22.40M
Other Income/Expenses
$ 3.08M$ 3.13M$ 2.25M$ 104.00K$ 7.36M
Pretax Income
$ -70.52M$ -37.37M$ -53.81M$ -49.98M$ -15.04M
Net Income
$ -70.52M$ -37.37M$ -51.56M$ -49.77M$ -14.94M
Per Share Metrics
Basic EPS
$ -1.63$ -1.05$ -1.79$ -1.82$ -0.52
Diluted EPS
$ -1.61$ -1.05$ -1.79$ -1.82$ -0.52
Weighted Average Shares Outstanding
43.33M 35.65M 28.86M 27.31M 28.66M
Weighted Average Shares Outstanding (Diluted)
43.86M 35.65M 28.86M 27.31M 28.66M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis